Shares of DRAXIS Health, Inc. (DRAX) Spike on Jubilant Acquisition
Shares of DRAXIS Health, Inc. (DRAX), a Toronto, Canada-based provider of specialty pharmaceuticals, jumped nearly 24% to an intraday high of $6.10 Friday after the company announced that will be acquired for approximately $255 million in cash by Indian company Jubilant Organosys, Ltd. Jubilant plans to acquire all the outstanding common shares of DRAXIS for $6 per share. Jubilant, a drug discovery and development services company, hopes the transaction will help it gain much-needed footing in North America. "DRAXIS represents a unique opportunity in the North American market, offering Jubilant entry into the attractive, regulated, high growth and high margin…